Drug
Glipizide
Glipizide: highest development phase Phase 1, developed by Sandoz. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.) NCT00946504 | Phase 1 | Type 2 Diabetes |
| 10 mg Glipizide Tablet (Geneva Pharmaceutical, Inc.), Administered Immediately After a Standard Breakfast. NCT00947024 | Phase 1 | Type 2 Diabetes |
Latest
No recent events.
Follow Glipizide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.